BackVeraxa Biotech Holding AG Overview

Veraxa Biotech Holding AG Receivables

Veraxa Biotech Holding AG's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Veraxa Biotech Holding AG Receivables History

Loading

Veraxa Biotech Holding AG vs. peers: Receivables Comparison

Loading

Veraxa Biotech Holding AG Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Veraxa Biotech Holding AG (VRXA) FAQ

Veraxa Biotech Holding AG (VRXA) currently reports a receivables of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Veraxa Biotech Holding AG's receivables history and peer comparisons.

Veraxa Biotech Holding AG's receivables changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Veraxa Biotech Holding AG reported $0 in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Veraxa Biotech Holding AG, and consider following VRXA for alerts when major investors trade the stock.